Company · CIK 0001521036 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
Lantheus Holdings, Inc. · LNTH
Insider activity reported against this company. All insider holders · Files at: CATX. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 FForm 4 → | Sep 2, 4:35 pm EDT | Robert J. Marshall Jr.CFO and Treasurer | 721 | $100.96 | $72,792 | 122,071 | — | |
| Aug 17, 2026 FForm 4 → | Aug 19, 4:34 pm EDT | Ludger DinkelborgSee Remarks | 2,536 | $100.91 | $255,908 | 33,195 | — | |
| Aug 17, 2026 FForm 4 → | Aug 19, 4:34 pm EDT | Kimberly BrownChief Accounting Officer | 463 | $100.91 | $46,721 | 13,263 | — | |
| May 14, 2026 FForm 4 → | Jun 3, 4:44 pm EDT | Gerard BerDirector | 381 | $96.67 | $36,831 | 27,118 | — | late |
| May 14, 2026 FForm 4 → | Jun 3, 4:43 pm EDT | Mary Anne HeinoExecutive Chair and CEO, Director | 1,227 | $96.67 | $118,614 | 321,897 | — | late |
| Mar 6, 2019 SForm 4 → | Mar 8, 4:35 pm EST | Cesare OrlandiChief Medical Officer | 4,271 | $22.77 | $97,238 | 79,733 | −5.08% | plan? |
| Mar 6, 2019 SForm 4 → | Mar 8, 4:33 pm EST | Julie McHughDirector | 2,595 | $22.77 | $59,075 | 17,510 | −12.9% | plan? |
| Mar 6, 2019 SForm 4 → | Mar 8, 4:32 pm EST | Gary J PrudenDirector | 3,192 | $22.77 | $72,672 | 10,072 | −24.1% | plan? |
| Mar 6, 2019 SForm 4 → | Mar 8, 4:32 pm EST | Michael P DuffySee Remarks | 1,789 | $22.77 | $40,734 | 160,221 | −1.10% | plan? |
| Mar 6, 2019 SForm 4 → | Mar 8, 4:32 pm EST | James H ThrallDirector | 3,500 | $22.78 | $79,723 | 9,764 | −26.4% | plan? |
| Mar 6, 2019 SForm 4 → | Mar 8, 4:30 pm EST | A Frederick RobertsonDirector | 3,932 | $22.77 | $89,536 | 43,062 | −8.37% | plan? |
| Mar 4, 2019 SForm 4 → | Mar 6, 4:30 pm EST | Mary Anne HeinoPresident & CEO, Director | 9,294 | $23.35 | $216,995 | 700,201 | −1.31% | plan? |
| Feb 27, 2019 SForm 4 → | Feb 28, 4:17 pm EST | Michael P DuffySee Remarks | 2,360 | $23.17 | $54,681 | 162,010 | −1.44% | plan? |
| Feb 27, 2019 SForm 4 → | Feb 28, 4:15 pm EST | Cesare OrlandiChief Medical Officer | 3,111 | $23.10 | $71,870 | 84,004 | −3.57% | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:24 pm EST | A Frederick RobertsonDirector | 5,353 | — | — | 46,994 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:21 pm EST | Derace L SchafferDirector | 5,353 | — | — | 56,994 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:18 pm EST | James H ThrallDirector | 5,353 | — | — | 13,264 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:17 pm EST | Robert J. Marshall Jr.CFO and Treasurer | 19,946 | — | — | 64,588 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:17 pm EST | Michael P DuffySee Remarks | 20,044 | — | — | 164,370 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:16 pm EST | John J. BollaSee Remarks | 16,154 | — | — | 38,774 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:16 pm EST | Julie McHughDirector | 5,353 | — | — | 20,105 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:16 pm EST | Sam R LenoDirector | 5,353 | — | — | 53,530 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:16 pm EST | Kenneth PucelDirector | 5,353 | — | — | 13,264 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:15 pm EST | Cesare OrlandiChief Medical Officer | 13,426 | — | — | 87,115 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:15 pm EST | James C ClemmerDirector | 5,353 | — | — | 53,987 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:15 pm EST | Gary J PrudenDirector | 5,353 | — | — | 13,264 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 28, 4:15 pm EST | Brian A MarkisonDirector | 5,353 | — | — | 97,467 | — | plan? |
| Feb 26, 2019 AForm 4 → | Feb 27, 4:16 pm EST | Mary Anne HeinoPresident & CEO, Director | 88,169 | — | — | 709,495 | — | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 4:16 pm EST | Mary Anne HeinoPresident & CEO, Director | 9,456 | $24.06 | $227,519 | 621,326 | −1.50% | plan? |
| Feb 6, 2019 SForm 4 → | Feb 8, 4:30 pm EST | Cesare OrlandiChief Medical Officer | 4,057 | $18.06 | $73,269 | 73,689 | −5.22% | plan? |
| Jan 31, 2019 SForm 4 → | Feb 1, 4:30 pm EST | Michael P DuffySee Remarks | 7,651 | $16.48 | $126,088 | 144,326 | −5.03% | plan? |
| Jan 31, 2019 SForm 4 → | Feb 1, 4:30 pm EST | Cesare OrlandiChief Medical Officer | 3,060 | $16.56 | $50,677 | 77,746 | −3.79% | plan? |
| Jan 30, 2019 SForm 4 → | Feb 1, 4:30 pm EST | Mary Anne HeinoPresident & CEO, Director | 9,564 | $16.47 | $157,497 | 630,782 | −1.49% | plan? |
| Nov 29, 2018 SForm 4 → | Dec 3, 4:30 pm EST | Cesare OrlandiChief Medical Officer | 7,055 | $18.01 | $127,075 | 80,806 | −8.03% | plan? |
| Oct 15, 2018 AForm 4 → | Oct 17, 4:30 pm EDT | Robert J. Marshall Jr.CFO and Treasurer | 44,642 | — | — | 44,642 | — | plan? |
| Sep 4, 2018 FForm 4 → | Sep 5, 4:30 pm EDT | Cesare OrlandiChief Medical Officer | 2,945 | $15.55 | $45,795 | 87,861 | — | plan? |
| Sep 4, 2018 FForm 4 → | Sep 5, 4:30 pm EDT | Michael P DuffySee Remarks | 5,501 | $15.55 | $85,541 | 151,977 | — | plan? |
| Aug 31, 2018 FForm 4 → | Sep 5, 4:31 pm EDT | Mary Anne HeinoPresident & CEO, Director | 9,699 | $16.10 | $156,154 | 640,346 | — | plan? |
| Jun 25, 2018 SForm 4 → | Jun 27, 5:06 pm EDT | Julie McHughDirector | 4,560 | $14.72 | $67,123 | 14,752 | −23.6% | plan? |
| Jun 15, 2018 AForm 4 → | Jun 19, 4:14 pm EDT | John J. BollaSee Remarks | 22,620 | — | — | 22,620 | — | plan? |
| May 1, 2018 SForm 4 → | May 3, 4:30 pm EDT | Cesare OrlandiChief Medical Officer | 4,510 | $18.04 | $81,370 | 90,806 | −4.73% | plan? |
| Apr 27, 2018 SForm 4 → | May 1, 5:14 pm EDT | Cesare OrlandiChief Medical Officer | 8,801 | $18.00 | $158,457 | 95,316 | −8.45% | plan? |
| Apr 26, 2018 FForm 4 → | Apr 27, 4:10 pm EDT | John W. CrowleyCFO | 4,565 | $17.90 | $81,714 | 161,825 | — | plan? |
| Apr 26, 2018 SForm 4 → | Apr 27, 4:10 pm EDT | Cesare OrlandiChief Medical Officer | 4,194 | $18.00 | $75,492 | 104,117 | −3.87% | plan? |
| Apr 26, 2018 FForm 4 → | Apr 27, 4:10 pm EDT | Cesare OrlandiChief Medical Officer | 3,314 | $17.90 | $59,321 | 108,311 | — | plan? |
| Apr 26, 2018 FForm 4 → | Apr 27, 4:10 pm EDT | Michael P DuffySee Remarks | 6,681 | $17.90 | $119,590 | 157,478 | — | plan? |
| Apr 26, 2018 FForm 4 → | Apr 27, 4:10 pm EDT | Mary Anne HeinoPresident & CEO, Director | 29,449 | $17.90 | $527,137 | 650,045 | — | plan? |
| Apr 3, 2018 SForm 4 → | Apr 5, 4:23 pm EDT | Michael P DuffySee Remarks | 27,313 | $15.30 | $417,897 | 164,159 | −14.3% | plan? |
| Apr 3, 2018 MForm 4 → | Apr 5, 4:23 pm EDT | Michael P DuffySee Remarks | 27,313 | $5.62 | $153,499 | 191,472 | — | plan? |
| Mar 14, 2018 SForm 4 → | Mar 16, 4:10 pm EDT | Michael P DuffySee Remarks | 11,492 | $16.60 | $190,775 | 164,159 | −6.54% | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:43 pm EST | Julie McHughDirector | 7,911 | — | — | 19,312 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:41 pm EST | Brian A MarkisonDirector | 7,911 | — | — | 92,114 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:39 pm EST | Sam R LenoDirector | 7,911 | — | — | 48,177 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:36 pm EST | John W. CrowleyCFO | 29,193 | — | — | 166,390 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:35 pm EST | James C ClemmerDirector | 7,911 | — | — | 48,634 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:35 pm EST | James H ThrallDirector | 7,911 | — | — | 7,911 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:34 pm EST | Michael P DuffySee Remarks | 24,967 | — | — | 175,651 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:33 pm EST | Timothy G HealeySVP, Commercial | 24,772 | — | — | 85,658 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:32 pm EST | Derace L SchafferDirector | 7,911 | — | — | 51,641 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:32 pm EST | A Frederick RobertsonDirector | 7,911 | — | — | 41,641 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:32 pm EST | Mary Anne HeinoPresident & CEO, Director | 120,253 | — | — | 679,494 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:31 pm EST | Kenneth PucelDirector | 7,911 | — | — | 7,911 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:31 pm EST | Cesare OrlandiChief Medical Officer | 25,629 | — | — | 111,625 | — | plan? |
| Mar 5, 2018 AForm 4 → | Mar 7, 4:30 pm EST | Gary J PrudenDirector | 7,911 | — | — | 7,911 | — | plan? |
| Feb 26, 2018 SForm 4 → | Feb 27, 5:03 pm EST | Timothy G HealeySVP, Commercial | 3,696 | $19.58 | $72,358 | 60,886 | −5.72% | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 5:03 pm EST | Timothy G HealeySVP, Commercial | 1,780 | $19.80 | $35,244 | 64,582 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 5:03 pm EST | Mary Anne HeinoPresident & CEO, Director | 6,526 | $19.80 | $129,215 | 559,241 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 5:01 pm EST | Michael P DuffySee Remarks | 1,617 | $19.80 | $32,017 | 150,684 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 5:00 pm EST | Cesare OrlandiChief Medical Officer | 1,082 | $19.80 | $21,424 | 85,996 | — | plan? |
| Feb 23, 2018 FForm 4 → | Feb 27, 5:00 pm EST | John W. CrowleyCFO | 1,459 | $19.80 | $28,888 | 137,197 | — | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 4:05 pm EST | John W. CrowleyCFO | 3,866 | $23.52 | $90,914 | 138,656 | −2.71% | plan? |
| Jan 10, 2018 SForm 4 → | Jan 12, 4:10 pm EST | Michael P DuffySee Remarks | 21,655 | $22.40 | $485,111 | 152,301 | −12.4% | plan? |
| Jan 10, 2018 MForm 4 → | Jan 12, 4:10 pm EST | Michael P DuffySee Remarks | 21,655 | $5.62 | $121,701 | 173,956 | — | plan? |
| Jan 1, 2018 FForm 4 → | Jan 3, 4:15 pm EST | John W. CrowleyCFO | 2,384 | $20.45 | $48,753 | 142,522 | — | plan? |
| Nov 17, 2017 SForm 4 → | Nov 17, 4:08 pm EST | Timothy G HealeySVP, Commercial | 11,314 | $21.51 | $243,400 | 66,362 | −14.6% | plan? |
| Nov 17, 2017 FForm 4 → | Nov 17, 4:08 pm EST | Timothy G HealeySVP, Commercial | 5,436 | $21.85 | $118,777 | 77,676 | — | plan? |
| Nov 14, 2017 SForm 4 → | Nov 16, 4:05 pm EST | Michael P DuffySee Remarks | 11,917 | $21.63 | $257,787 | 152,301 | −7.26% | plan? |
| Oct 13, 2017 SForm 4 → | Oct 17, 4:14 pm EDT | John W. CrowleyCFO | 6,755 | $18.41 | $124,366 | 144,906 | −4.45% | plan? |
| Sep 12, 2017 SForm 4 → | Sep 14, 5:07 pm EDT | Derace L SchafferDirector | 15,000 | $17.50 | $262,500 | 43,730 | −25.5% | plan? |
| Sep 11, 2017 SForm 4 → | Sep 13, 4:10 pm EDT | Michael P DuffySee Remarks | 20,000 | $16.45 | $328,978 | 164,218 | −10.9% | plan? |
| Sep 11, 2017 MForm 4 → | Sep 13, 4:10 pm EDT | Michael P DuffySee Remarks | 20,000 | $5.62 | $112,400 | 184,218 | — | plan? |
| Sep 7, 2017 SForm 4 → | Sep 11, 9:00 pm EDT | David F BurgstahlerDirector | 102,958 | $16.56 | $1,704,984 | 38,269 | −72.9% | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 5:35 pm EDT | Cesare OrlandiChief Medical Officer | 18,000 | $16.69 | $300,476 | 87,078 | −17.1% | plan? |
| Sep 1, 2017 SForm 4 → | Sep 6, 9:00 pm EDT | David F BurgstahlerDirector | 78,833 | $16.95 | $1,336,384 | 52,684 | −59.9% | plan? |
| Sep 1, 2017 FForm 4 → | Sep 1, 8:12 pm EDT | Cesare OrlandiChief Medical Officer | 3,245 | $16.80 | $54,516 | 105,078 | — | plan? |
| Sep 1, 2017 FForm 4 → | Sep 1, 8:12 pm EDT | Michael P DuffySee Remarks | 4,016 | $16.80 | $67,469 | 164,218 | — | plan? |
| Sep 1, 2017 FForm 4 → | Sep 1, 8:11 pm EDT | William C. Dawes Jr.VP, Mfg & Ops | 3,245 | $16.80 | $54,516 | 111,581 | — | plan? |
| Sep 1, 2017 FForm 4 → | Sep 1, 8:11 pm EDT | John W. CrowleyCFO | 3,245 | $16.80 | $54,516 | 151,661 | — | plan? |
| Aug 31, 2017 FForm 4 → | Sep 1, 4:15 pm EDT | Mary Anne HeinoPresident & CEO, Director | 26,701 | $17.50 | $467,268 | 565,767 | — | plan? |
| Aug 29, 2017 SForm 4 → | Aug 31, 9:00 pm EDT | David F BurgstahlerDirector | 230,685 | $17.25 | $3,979,680 | 65,263 | −77.9% | plan? |
| Aug 24, 2017 SForm 4 → | Aug 28, 8:29 pm EDT | David F BurgstahlerDirector | 91,166 | $17.01 | $1,550,885 | 97,479 | −48.3% | plan? |
| Aug 14, 2017 JForm 4 → | Aug 16, 8:06 pm EDT | Avista Capital Partners GP, LLC +310% Owner | 5,363,589 | $17.15 | $91,985,551 | 0 | — | plan? |
| Aug 14, 2017 SForm 4 → | Aug 16, 8:06 pm EDT | Avista Capital Partners GP, LLC +310% Owner | 140,846 | $17.27 | $2,432,665 | 122,492 | −53.5% | plan? |
| Aug 14, 2017 JForm 4 → | Aug 16, 8:05 pm EDT | David F BurgstahlerDirector | 5,378,399 | $17.15 | $91,985,551 | 1,562 | — | plan? |
| Aug 14, 2017 SForm 4 → | Aug 16, 8:05 pm EDT | David F BurgstahlerDirector | 140,846 | $17.27 | $2,432,665 | 122,492 | −53.5% | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 4:05 pm EDT | Cesare OrlandiChief Medical Officer | 18,672 | — | — | 108,323 | — | plan? |
| Jul 12, 2017 SForm 4 → | Jul 14, 4:15 pm EDT | Mary Anne HeinoPresident & CEO, Director | 10,000 | $18.05 | $180,500 | 592,468 | −1.66% | plan? |
| Jun 20, 2017 SForm 4 → | Jun 22, 8:12 pm EDT | Avista Capital Partners GP, LLC +310% Owner | 3,000,000 | $14.87 | $44,610,000 | 1,762,208 | −63.0% | plan? |
| Jun 20, 2017 SForm 4 → | Jun 22, 8:09 pm EDT | David F BurgstahlerDirector, 10% Owner | 3,000,000 | $14.87 | $44,610,000 | 1,762,208 | −63.0% | plan? |
| Jun 12, 2017 SForm 4 → | Jun 12, 4:05 pm EDT | Michael P DuffySee Remarks | 20,000 | $15.42 | $308,400 | 168,234 | −10.6% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2018 MForm 4 → | Apr 5, 4:23 pm EDT | Michael P DuffySee Remarks | 27,313 | — | — | 0 | — | |
| Jan 10, 2018 MForm 4 → | Jan 12, 4:10 pm EST | Michael P DuffySee Remarks | 21,655 | — | — | 0 | — | |
| Sep 11, 2017 MForm 4 → | Sep 13, 4:10 pm EDT | Michael P DuffySee Remarks | 20,000 | — | — | 4,484 | — | |
| Jun 12, 2017 MForm 4 → | Jun 12, 4:05 pm EDT | Michael P DuffySee Remarks | 20,000 | — | — | 24,484 | — | |
| Jul 9, 2015 AForm 4 → | Jul 9, 4:20 pm EDT | James C ClemmerDirector | 6,993 | — | — | 6,993 | — | |
| Jun 25, 2015 AForm 4 → | Jun 25, 7:34 pm EDT | Patrick O'NeillDirector | 8,333 | — | — | 8,333 | — | |
| Jun 25, 2015 ADForm 4 → | Jun 25, 7:34 pm EDT | Mary Anne HeinoChief Operating Officer | 22,242 | — | — | 11,121 | — | |
| Jun 25, 2015 ADForm 4 → | Jun 25, 7:33 pm EDT | Cesare OrlandiChief Medical Officer | 13,346 | — | — | 6,673 | — | |
| Jun 25, 2015 ADForm 4 → | Jun 25, 7:33 pm EDT | John W. CrowleyVP Finance and Accounting | 1,708 | — | — | 854 | — | |
| Jun 25, 2015 AForm 4 → | Jun 25, 7:32 pm EDT | Sam R LenoDirector | 8,333 | — | — | 8,333 | — | |
| Jun 25, 2015 ADForm 4 → | Jun 25, 7:31 pm EDT | Jeffrey Allen BaileyCEO and President, Director | 355,872 | — | — | 177,936 | — | |
| Jun 25, 2015 ADForm 4 → | Jun 25, 7:30 pm EDT | William C. Dawes Jr.VP Mfrg and Operations | 71,016 | — | — | 35,508 | — | |
| Jun 25, 2015 AForm 4 → | Jun 25, 7:30 pm EDT | Brian A MarkisonDirector | 16,666 | — | — | 16,666 | — | |
| Jun 25, 2015 ADForm 4 → | Jun 25, 7:27 pm EDT | Michael P DuffyVP, General Counsel, Secretary | 54,628 | — | — | 27,314 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 4:54 pm EDT | Perspective Therapeutics, Inc.CATX | 35,769 | $3.12 | $111,574 | 11,563,425 | −0.31% | |
| Aug 31, 2026 SForm 4 → | Sep 2, 4:36 pm EDT | Perspective Therapeutics, Inc.CATX | 78,145 | $3.14 | $245,610 | 11,599,194 | −0.67% |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.